Fri, Aug 22, 2014, 1:12 AM EDT - U.S. Markets open in 8 hrs 18 mins

Recent

% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

  • thirdmeinvestor thirdmeinvestor Mar 9, 2007 7:30 AM Flag

    Check this

    .....
    Meanwhile, Bumblebee Biotech offers this analysis of Alnylam Pharmaceuticals (ALNY - Cramer's Take - Stockpickr - Rating).
    Alnylam -- along with Sirna Therapeutics (RNAI - Cramer's Take - Stockpickr - Rating), CytRx (CYTR - Cramer's Take - Stockpickr - Rating) and numerous other private firms such as Calando -- is developing the most promising drug treatments based on RNAi since the discovery of recombinant DNA and the founding of Genentech (DNA - Cramer's Take - Stockpickr - Rating) in the '70s.

    Alnylam is smart enough look [to] elsewhere for its drug delivery technology, and therefore ahead of the game. Inex Pharmaceuticals ... is the drug platform match to Alnylam. In our opinion, Alnylam is the only firm with a potentially workable drug delivery partner. Neither CytRx nor Sirna Therapeutics have known drug delivery partners, which is a critical issue.

    *****************

    ALNY will be back in the 20's soon!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ALNY
65.36-1.97(-2.93%)Aug 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.